Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Statement of Comprehensive Income [Abstract]
Collaboration revenues	$ 19,632	$ 14,919
Operating expenses:
Research and development	59,673	74,125
General and administrative	22,138	29,525
Total operating expenses	81,811	103,650
Operating loss	(62,179)	(88,731)
Change in fair value of derivative liability	0	(84)
Interest income, net	1,702	1,936
Net loss	$ (60,477)	$ (86,879)
Share information:
Net loss per share of common stock, basic (in USD per share)	$ (1.46)	$ (2.59)
Net loss per share of common stock, diluted (in USD per share)	$ (1.46)	$ (2.59)
Weighted-average shares of common stock outstanding, basic (in shares)	41,456,210	33,524,197
Weighted-average shares of common stock outstanding, diluted (in shares)	41,456,210	33,524,197
Comprehensive loss
Net loss	$ (60,477)	$ (86,879)
Unrealized gain on marketable securities	0	440
Less: reclassification to net loss of previous unrealized gain on marketable securities	0	(399)
Comprehensive loss	$ (60,477)	$ (86,838)